Submission Details
| 510(k) Number | K142826 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 30, 2014 |
| Decision Date | December 22, 2015 |
| Days to Decision | 448 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K142826 is an FDA 510(k) clearance for the ADVIA Centaur Toxoplasma M (Toxo M), a Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii (Class II — Special Controls, product code LGD), submitted by Siemens Healthcare Diagnostics, Inc. (New York, US). The FDA issued a Cleared decision on December 22, 2015, 448 days after receiving the submission on September 30, 2014. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3780.
| 510(k) Number | K142826 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 30, 2014 |
| Decision Date | December 22, 2015 |
| Days to Decision | 448 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LGD — Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3780 |